← FDA Drug Approvals (Drugs@FDA)
SIMVASTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2017-11-13
Drug application
- FDA Application #
ANDA206557- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SIMVASTATIN
- Generic name
- Simvastatin
- Active ingredients
- SIMVASTATIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INVAGEN PHARMS
- First approval
- 2017-11-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown